Can SARS-CoV-2 Be Treated With Small Molecules?
Although several COVID19 vaccines have been approved and population immunity rates are increasing, it will still be a long time until everyone is immune. Until
Although several COVID19 vaccines have been approved and population immunity rates are increasing, it will still be a long time until everyone is immune. Until
Several studies have been performed demonstrating the applicability of IgY in diagnostic virology where it can be used as a biological input in immunoassays. In the first outbreak of SARS-CoV, an immunoswab assay was developed to detect the SARS-CoV nucleocapsid protein of the virus and compared the use of an IgG monoclonal antibody (mAb) with a chicken IgY antibody.
Although several COVID19 vaccines have been approved and population immunity rates are increasing, it will still be a long time until everyone is immune. Until
Several studies have been performed demonstrating the applicability of IgY in diagnostic virology where it can be used as a biological input in immunoassays. In the first outbreak of SARS-CoV, an immunoswab assay was developed to detect the SARS-CoV nucleocapsid protein of the virus and compared the use of an IgG monoclonal antibody (mAb) with a chicken IgY antibody.
Subscribe to receive product updates & promotions.